Hydrogen sulfide stimulates catecholamine secretion in rainbow trout (Oncorhynchus mykiss).
We tested the hypothesis that endogenously produced hydrogen sulfide (H(2)S) can potentially contribute to the adrenergic stress response in rainbow trout by initiating catecholamine secretion from chromaffin cells. During acute hypoxia (water Po(2) = 35 mmHg), plasma H(2)S levels were significantly elevated concurrently with a rise in circulating catecholamine concentrations. Tissues enriched with chromaffin cells (posterior cardinal vein and anterior kidney) produced H(2)S in vitro when incubated with l-cysteine. In both tissues, the production of H(2)S was eliminated by adding the cystathionine beta-synthase inhibitor, aminooxyacetate. Cystathionine beta-synthase and cystathionine gamma-lyase were cloned and sequenced and the results of real-time PCR demonstrated that with the exception of white muscle, mRNA for both enzymes was broadly distributed within the tissues that were examined. Electrical field stimulation of an in situ saline-perfused posterior cardinal vein preparation caused the appearance of H(2)S and catecholamines in the outflowing perfusate. Perfusion with the cholinergic receptor agonist carbachol (1 x 10(-6) M) or depolarizing levels of KCl (1 x 10(-2) M) caused secretion of catecholamines without altering H(2)S output, suggesting that neuronal excitation is required for H(2)S release. Addition of H(2)S (at concentrations exceeding 5 x 10(-7) M) to the perfusion fluid resulted in a marked stimulation of catecholamine secretion that was not observed when Ca(2+)-free perfusate was used. These data, together with the finding that H(2)S-induced catecholamine secretion was unaltered by the nicotinic receptor blocker hexamethonium, suggest that H(2)S is able to directly elicit catecholamine secretion via membrane depolarization followed by Ca(2+)-mediated exocytosis.
Perry
Steve F
SF
Dept. of Biology, Univ. of Ottawa, 30 Marie Curie, Ottawa, Ontario K1N 6N5, Canada. sfperry@uottawa.ca
McNeill
Brian
B
Elia
Eshay
E
Nagpal
Ashish
A
Vulesevic
Branka
B
D000818:Animals; D020013:Calcium Signaling; D018679:Cholinergic Agonists / Q000494:pharmacology; D019439:Chromaffin Cells / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D003001:Cloning, Molecular; D003541:Cystathionine beta-Synthase / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism; D003542:Cystathionine gamma-Lyase / Q000235:genetics / Q000378:metabolism; D003545:Cysteine / Q000378:metabolism; D004558:Electric Stimulation; D004791:Enzyme Inhibitors / Q000494:pharmacology; D004837:Epinephrine / Q000097:blood / Q000378:metabolism*; D005089:Exocytosis; D005260:Female; D029941:Fish Proteins / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism; D015971:Gene Expression Regulation, Enzymologic; D006862:Hydrogen Sulfide / Q000097:blood / Q000378:metabolism*; D000860:Hypoxia / Q000097:blood / Q000378:metabolism* / Q000503:physiopathology; D008297:Male; D008564:Membrane Potentials; D018733:Nicotinic Antagonists / Q000494:pharmacology; D009638:Norepinephrine / Q000097:blood / Q000378:metabolism*; D017686:Oncorhynchus mykiss / Q000097:blood / Q000378:metabolism*; D010477:Perfusion; D010802:Phylogeny; D012333:RNA, Messenger / Q000378:metabolism; D013312:Stress, Physiological; D013997:Time Factors
D018679:Cholinergic Agonists; D004791:Enzyme Inhibitors; D029941:Fish Proteins; D018733:Nicotinic Antagonists; D012333:RNA, Messenger; D003541:Cystathionine beta-Synthase; D003542:Cystathionine gamma-Lyase; D003545:Cysteine; D009638:Norepinephrine; D004837:Epinephrine; D006862:Hydrogen Sulfide